Nautilus Bio lines up SPAC merger and $350M in funding for proteomics R&D February 8, 2021 Auto Bot Artificial Intelligence, BioPharma, biopharma nl, biotech IPO, Diagnostics, Pharma, Seattle 0 Nautilus, among the biotechs developing protein analysis tools for drug discovery and diagnostics, already has a partnership with Genentech. As it prepares to go public, Nautilus aims to do for proteomics what Illumina did for genomics.